Drug class in one race
PD-L1 + 4-1BB (CD137) drugs for Non-Small Cell Lung Cancer
2 tracked PD-L1 + 4-1BB (CD137) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the PD-L1 + 4-1BB (CD137) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1/2